Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study

• Váldodahkkit: Indraneel Basu (Dahkki), Manish Agarwal (Dahkki), Viral Shah (Dahkki), Vijay Shukla (Dahkki), Sunil Naik (Dahkki), Pravin Dinkar Supe (Dahkki), Manoj Kumar Srivastava (Dahkki), Kanakapura Vrushabaiah Giriraja (Dahkki), Peersab Pinjar (Dahkki), Pradeep Kumar Mishra (Dahkki), Shishir Joshi (Dahkki), Ranjit Vijayakumar (Dahkki), Serge van de Witte (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background This study was conducted to compare the immunogenicity and safety profile of two quadrivalent influenza vaccines (QIVs) in healthy adults (18-60 years) and elderly (>61 years) participants. Method This phase III study was conducted from March 2018 to April 2018 across 12 sites in India...